DEANNE BABIO: Open Payments
NPI 1124681697 · EASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 5 payments from 5 companies in 2025. Trend: 2023 $369 · 2024 $773 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
Products named: Livdelzi, Wegovy, REZDIFFRA, ENTYVIO, LOKELMA.
Industry payments across PA — which companies pay providers there.
